Amaranth Medical Overview

Amaranth Medical Inc. is a Delaware C-corporation incorporated in August 2006 to commercialize biodegradable stents to treat peripheral vascular disease (PVD). The company is a research and development stage firm with offices in Palo Alto, California and in Singapore. Amaranth has obtained US$ 7.5M of financing through a Series A investment led by Charter Life Sciences of Palo Alto, and Bio*One...More»

Amaranth Medical Inc. is a Delaware C-corporation incorporated in August 2006 to commercialize biodegradable stents to treat peripheral vascular disease (PVD). The company is a research and development stage firm with offices in Palo Alto, California and in Singapore. Amaranth has obtained US$ 7.5M of financing through a Series A investment led by Charter Life Sciences of Palo Alto, and Bio*One Capital of Singapore. The funds will be used to advance the technology into proof-of-concept studies in man.

Amaranth's core technology was developed in Singapore, at the Nanyang Technological University's School of Material Science & Engineering. The Dean of the School of Material Science & Engineering, Prof Freddy Boey, and the school's Vice Dean, Prof Subbu Venkatraman, have worked together over the last decade on novel materials. Amaranth is now focused on progressing its stents to the preclinical/clinical stages in the United States.«Less